Girinimbine

CAS No. 23095-44-5

Girinimbine( —— )

Catalog No. M37784 CAS No. 23095-44-5

Girinimbine (Girinimbin) is a carbazole alkaloid isolated from the plants M. koenigii, M. koenigii, and Murraya koenigii.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 628 Get Quote
5MG 930 Get Quote
10MG 1254 Get Quote
25MG 1803 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Girinimbine
  • Note
    Research use only, not for human use.
  • Brief Description
    Girinimbine (Girinimbin) is a carbazole alkaloid isolated from the plants M. koenigii, M. koenigii, and Murraya koenigii.
  • Description
    Girinimbine (Girinimbin) is a carbazole alkaloid with a variety of biological effects. Girinimbine can induce apoptosis, and has antitrypanosomal, antiplatelet activity, antibacterial activity, anti-inflammatory, antioxidant and antitumor activities.
  • In Vitro
    Girinimbine (1-400 μM; 24-72 h) decreases the viability of HepG2 cells in 24, 48 and 72 h with IC50 values of 61 μM, 56 μM, and 40 μM respectively. Girinimbine (10-100 μM; 24-48 h) increase of LDH leakage in both concentration- and time-dependent manner in HepG2 cells.Girinimbine (56 μM; 24-48 h) treatment results in DNA fragmentation and elevates levels of caspase-3 in HepG2 cells.HepG2 cells.Girinimbine (56 μM; 12-48 h) treatment also displays a time-dependent accumulation of the Sub-G0/G1 peak (hypodiploid) and caused G0/G1-phase arrest.Girinimbine shows a potent antitrypanosomal activitywith an IC50 value of 10.16 μg/mL.Cell Viability Assay Cell Line:HepG2 cells Concentration:1 μM, 10 μM, 50 μM, 100 μM, 200 μM Incubation Time:24 h, 48 h and 72 h Result:Inhibited the proliferation of HepG2 cells in vitro in a dose- and time-dependent manner.Apoptosis Analysis Cell Line:HepG2 cells Concentration:56 μM Incubation Time:24 h, 48 h Result:Showed typical morphological features of apoptosis.Cell Cycle Analysis Cell Line:HepG2 cells Concentration:56 μM Incubation Time:12 h, 24 h, 48 h Result:Induced G0/G1-phase arrest in HepG2 cells.
  • In Vivo
    Girinimbine (10-100 mg/kg; orally gavage; once) pretreatment helps limit total leukocyte migration, and reduced pro-inflammatory cytokine (IL-1β, TNF-α) levels in the peritoneal fluid. In vivo in zebrafish embryos, Girinimbine (20 μg/mL; 24 hours) shows significant distribution of apoptotic cells in embryos.Animal Model:Male ICR mice (25-35 g) treated with carrageenan Dosage:10 mg/kg, 30 mg/kg, and 100 mg/kg Administration: Orally gavage; once Result:Helped limit total leukocyte migration, and reduced pro-inflammatory cytokine levels in the peritoneal fluid.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Antioxidant
  • Recptor
    Antioxidant | Apoptosis | Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    23095-44-5
  • Formula Weight
    263.33
  • Molecular Formula
    C18H17NO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1cc2c3ccccc3[nH]c2c2C=CC(C)(C)Oc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Suvitha Syam, et al. The growth suppressing effects of girinimbine on HepG2 involve induction of apoptosis and cell cycle arrest. Molecules. 2011 Aug 23;16(8):7155-70.?
molnova catalog
related products
  • Kadsurin

    Kadsurin has anti-oxidant activity, it induces enzymes capable of scavenging oxygen radical species in the liver.

  • BMY 7378 dihydrochlo...

    BMY-7378, α1D-adrenergic receptor antagonist, is a weak partial agonist/antagonist of 5-HT1A receptor.

  • KukoaMine B

    Kukoamine B is a component of Lycii Cortex with anti-oxidant anti-acute inflammatory and anti-diabetic properties.